NCT07148505View on ClinicalTrials.gov

A Study of Real-world Outcomes Among Patients Treated With Ribociclib

CompletedOBSERVATIONAL
Enrollment

373

Participants

Timeline

Start Date

April 24, 2024

Primary Completion Date

November 7, 2024

Study Completion Date

November 7, 2024

Conditions
Metastatic Breast Cancer
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY